Annual Working Capital
$752.97 M
-$154.20 M-17.00%
31 December 2023
Summary:
AbCellera Biologics annual working capital is currently $752.97 million, with the most recent change of -$154.20 million (-17.00%) on 31 December 2023. During the last 3 years, it has risen by +$43.14 million (+6.08%). ABCL annual working capital is now -17.00% below its all-time high of $907.17 million, reached on 31 December 2022.ABCL Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Working Capital
$663.32 M
-$37.86 M-5.40%
30 September 2024
Summary:
AbCellera Biologics quarterly working capital is currently $663.32 million, with the most recent change of -$37.86 million (-5.40%) on 30 September 2024. Over the past year, it has dropped by -$145.96 million (-18.04%). ABCL quarterly working capital is now -30.97% below its all-time high of $960.96 million, reached on 31 March 2022.ABCL Quarterly Working Capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABCL Working Capital Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -17.0% | -18.0% |
| 3 y3 years | +6.1% | -12.1% |
| 5 y5 years | +8526.2% | - |
ABCL Working Capital High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -17.0% | +6.1% | -31.0% | at low |
| 5 y | 5 years | -17.0% | >+9999.0% | -31.0% | >+9999.0% |
| alltime | all time | -17.0% | >+9999.0% | -31.0% | >+9999.0% |
AbCellera Biologics Working Capital History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $663.32 M(-5.4%) |
| June 2024 | - | $701.17 M(-1.1%) |
| Mar 2024 | - | $709.07 M(-5.8%) |
| Dec 2023 | $752.97 M(-17.0%) | $752.97 M(-7.0%) |
| Sept 2023 | - | $809.28 M(-0.3%) |
| June 2023 | - | $811.83 M(-4.6%) |
| Mar 2023 | - | $851.06 M(-6.2%) |
| Dec 2022 | $907.17 M | $907.17 M(-3.5%) |
| Sept 2022 | - | $939.62 M(+1.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $922.82 M(-4.0%) |
| Mar 2022 | - | $960.96 M(+18.8%) |
| Dec 2021 | $809.12 M(+14.0%) | $809.12 M(+7.3%) |
| Sept 2021 | - | $754.20 M(-5.0%) |
| June 2021 | - | $794.24 M(-3.1%) |
| Mar 2021 | - | $819.59 M(+15.5%) |
| Dec 2020 | $709.84 M(>+9900.0%) | $709.84 M(+656.0%) |
| Sept 2020 | - | $93.90 M(+1878.8%) |
| Dec 2019 | $4.75 M(-45.6%) | $4.75 M |
| Dec 2018 | $8.73 M | - |
FAQ
- What is AbCellera Biologics annual working capital?
- What is the all time high annual working capital for AbCellera Biologics?
- What is AbCellera Biologics annual working capital year-on-year change?
- What is AbCellera Biologics quarterly working capital?
- What is the all time high quarterly working capital for AbCellera Biologics?
- What is AbCellera Biologics quarterly working capital year-on-year change?
What is AbCellera Biologics annual working capital?
The current annual working capital of ABCL is $752.97 M
What is the all time high annual working capital for AbCellera Biologics?
AbCellera Biologics all-time high annual working capital is $907.17 M
What is AbCellera Biologics annual working capital year-on-year change?
Over the past year, ABCL annual working capital has changed by -$154.20 M (-17.00%)
What is AbCellera Biologics quarterly working capital?
The current quarterly working capital of ABCL is $663.32 M
What is the all time high quarterly working capital for AbCellera Biologics?
AbCellera Biologics all-time high quarterly working capital is $960.96 M
What is AbCellera Biologics quarterly working capital year-on-year change?
Over the past year, ABCL quarterly working capital has changed by -$145.96 M (-18.04%)